Syngen Biotech Co.,Ltd.

8279 · TWO · Healthcare / Biotechnology

80.30TWD-0.20 (-0.25%)

Price History

Full chart

Market Stats

Previous Close80.50

Open80.30

Day Range80.20 – 80.80

52-Week Range77.60 – 133.58

Volume20.08K

Market Cap2.15B

P/E (TTM)9.54

Forward P/E0.00

EPS8.33

Dividend Yield6.29%

Beta0.13

50-Day Avg82.82

200-Day Avg101.30

About

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, and capsules; and elderly health care, beauty enhancing supplements, probiotics, digestive aids and enzymes, weight loss and nutrition, immune acid, fitness and energy, and pet supplement products. It also provides science-based and bio active pharmaceutical ingredients, including Oraltics, a lactobacillus fermentum SG-A95; IMMUPHYLA, a heat-killed lactobacillus paracasei LCW23; V3, a lactobacillus fermentum; ST4SanTex, a streptococcus thermophilus; GUARDSPO, a bacillus coagulans; benefiGANO, a ganoderma lucidum, EXPUNERGY, a hirsutella sinensis mycelium; and BIOJOVIAL, a lactobacillus brevis. In addition, the company offers organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. It serves sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox industries. Syngen Biotech Co.,Ltd. was founded in 1988 and is based in Tainan City, Taiwan.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOWei Ren Chen
Employees0
HeadquartersBuilding A, Tainan City, Taiwan, 73055, Taiwan
Websitehttps://www.syngen.com.tw

Leadership

Wei Ren ChenChairman of the Board and President
Zhi Ming HuangFinance Manager
Zihui WangAccounting Supervisor

Financials

Income Statement

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.47B	1.93B	1.84B	2.01B	2.14B
Growth (%)	-	+31.22%	-4.84%	+9.60%	+6.10%
Cost of Revenue	942.93M	1.24B	1.19B	1.29B	1.41B
Gross Profit	528.34M	688.15M	643.92M	723.94M	723.59M
Gross Margin	35.91%	35.64%	35.05%	35.95%	33.87%
Operating Expense	246.54M	307.96M	349.64M	413.72M	399.63M
Operating Income	281.80M	380.20M	294.28M	310.22M	323.96M
Operating Margin	19.15%	19.69%	16.02%	15.41%	15.16%
EBITDA	-	487.99M	442.14M	423.57M	461.82M
EBITDA Margin	-	25.28%	24.07%	21.04%	21.62%
Net Income	237.77M	321.24M	274.83M	240.21M	271.59M
Net Income Margin	16.16%	16.64%	14.96%	11.93%	12.71%
R&D	49.52M	45.32M	46.76M	59.34M	60.56M
R&D as % of Total Revenue	3.37%	2.35%	2.54%	2.95%	2.83%
Interest Expense	3.21M	5.07M	8.86M	9.28M	5.65M
Interest Expense % of Total Revenue	0.22%	0.26%	0.48%	0.46%	0.26%

Balance Sheet

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.42B	3.07B	3.11B	3.08B	3.05B
Total Liabilities	644.16M	1.08B	974.63M	848.52M	674.89M
Total Equity	1.77B	1.99B	2.13B	2.24B	2.37B
Cash	314.80M	246.05M	366.89M	341.93M	275.46M
Net Debt	-	351.70M	138.39M	27.91M	-

Cash Flow

Currency: TWD	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-	336.50M	277.48M	415.13M	348.04M	319.48M
Capital Expenditure	0	61.67M	584.71M	93.80M	64.34M	76.42M
Free Cash Flow	-	274.83M	-307.23M	321.33M	283.70M	243.07M
Dividends Paid	-	94.85M	108.40M	135.50M	135.50M	135.50M
FCF to OCF	-	81.67%	-110.72%	77.40%	81.51%	76.08%
Dividend Paid to FCF	-	34.51%	-35.28%	42.17%	47.76%	55.75%

Earnings

Report Date	Nov 10, 2017	May 9, 2018	Aug 9, 2018	Nov 8, 2018	May 9, 2019	Aug 7, 2019	Nov 6, 2019	Mar 25, 2020	Aug 13, 2020	Oct 30, 2020	May 3, 2021	Jul 28, 2021	Nov 10, 2021	Apr 27, 2022	Jul 27, 2022	Oct 26, 2022	May 12, 2023	Aug 7, 2023	Oct 30, 2023	Dec 31, 2023	May 13, 2024	Aug 1, 2024	Oct 31, 2024
EPS Estimate	1.89	0.77	1.99	3.07	1.55	1.86	2.64	1.77	-	-	-	-	-	1.84	2.72	-	2.87	3.75	3.65	1.99	2.74	-	-
EPS Actual	2.51	0.65	1.20	2.07	1.46	2.55	1.97	1.88	2.75	2.20	1.53	2.25	2.54	2.41	3.53	3.37	2.69	2.76	2.59	2.10	2.20	1.84	2.67
Surprise	32.80%	-15.58%	-39.70%	-32.57%	-5.81%	37.10%	-25.38%	6.21%	-	-	-	-	-	30.98%	29.78%	-	-6.27%	-26.40%	-29.04%	5.53%	-19.71%	-	-
Timing	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	After-hours	-	Pre-market	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap2.15B

Enterprise Value2.19B

Trailing P/E9.54

Forward P/E0.00

Price / Sales1.05

Price / Book0.90

EPS8.33

Book Value86.39

Revenue (TTM)2.05B

Gross Profit (TTM)653.46M

EBITDA367.69M

Profit Margin11.01%

Operating Margin14.17%

Return on Equity9.85%

Return on Assets5.31%

Shares Outstanding27.10M

Shares Float10.96M

Beta0.13

Dividend Yield6.29%

Dividend Rate5.00

Payout Ratio60.03%

Dividends

20261×

5.00Jun 25, 2026

20251×

5.00Jun 26, 2025

20241×

5.00Jun 27, 2024

20231×

5.00Jun 29, 2023

20221×

4.00Jun 16, 2022

20211×

3.50Sep 6, 2021

20201×

3.00Jul 2, 2020

20191×

2.45Jun 28, 2019

20181×

0.98Jul 9, 2018

20171×

0.89Jun 20, 2017

20161×

0.45Jun 20, 2016

Stock Splits

Jul 9, 20181100:1000